Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral misoprostol versus intravenous oxytocin for labor induction after premature rupture of membranes
IRCT20191014045106N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Rupture of amniotic membranes (PROM) comparing Oral misoprostol with Intravenous oxytocin plus oral placebo (2 arms). Primary endpoints: Induction of labor with misoprostol, Induction of labor with oxytocin and 4 more. Started Nov 2019; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
Rupture of amniotic membranes (PROM)
Beyond the preview
Go deeper on IRCT20191014045106N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191014045106N1.